We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

This study has been withdrawn prior to enrollment.
(Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00329316
First Posted: May 24, 2006
Last Update Posted: June 27, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
The Baruch Padeh Medical Center, Poriya
  Purpose
To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Condition Intervention
Pregnancy Premature Birth Drug: Crinone Gel 8%

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)

Resource links provided by NLM:


Further study details as provided by The Baruch Padeh Medical Center, Poriya:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

Exclusion Criteria:

  • No medications for PTL or any kind of progesterone.
  • Cervical suture
  • Multiple pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00329316


Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Study Chair: Yuri Perlitz, MD The Baruch Padeh Medical Center, Poriya
Principal Investigator: Mosheh Ben Ami, Prof. Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya
  More Information

ClinicalTrials.gov Identifier: NCT00329316     History of Changes
Other Study ID Numbers: PTL Progesterone Perlitz.CTIL
First Submitted: May 23, 2006
First Posted: May 24, 2006
Last Update Posted: June 27, 2008
Last Verified: June 2007

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Pre-term labor
progesterone

Additional relevant MeSH terms:
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Progesterone
Progestins
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs